Dr Karen Mullen
pharmafile | May 6, 2022 | Appointment | |
Dr Karen Mullen joins Boyds from GlaxoSmithKline, where, as Country Medical Director for UK and Ireland, she led and managed a large medical department across clinical research, pharma, and vaccines. Karen’s previous roles at GSK include Head of Medical Affairs, Director of Vaccines, and Director of Metabolic Medicine.
Karen has over 20 years of experience in medical affairs and R&D in Europe, the US, and Australia. At Boyds, Karen will lead the Clinical and Medical Affairs department, as well as its team of pharmaceutical physicians, providing medical monitoring support, and safety, pharmacovigilance, scientific and medical advice across a wide range of client projects – including advanced therapies, and orphan drugs.